About Avextra
Avextra is a company based in Berlin (Germany) founded in 2004 by Bernhard Babylon and David Reckeweg Lecompte.. Avextra has raised $48.08 million across 4 funding rounds from investors including Fastforward Innovations and Iberis Capital. Avextra offers products and services including THC/CBD Quick Test and Cannabis Extract. Avextra operates in a competitive market with competitors including Tilray, iuvo Therapeutics, Canobo, LIO Pharmaceuticals and enua Pharma, among others.
- Headquarter Berlin, Germany
- Founders Bernhard Babylon, David Reckeweg Lecompte
-
Sectors
HealthcareConsumer
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avextra Pharma Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.08 M (USD)
in 4 rounds
-
Latest Funding Round
$21.49 M (USD), Series B
Feb 07, 2024
-
Investors
Fastforward Innovations
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avextra
Avextra offers a comprehensive portfolio of products and services, including THC/CBD Quick Test and Cannabis Extract. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid test kit for detecting THC and CBD levels in samples
Standardized extract for medical treatments and therapies
Funding Insights of Avextra
Avextra has successfully raised a total of $48.08M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $21.49 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $21.5M
-
First Round
First Round
(05 Jul 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series B - Avextra | Valuation |
investors |
|
| Mar, 2023 | Amount | Series B - Avextra | Valuation |
investors |
|
| Apr, 2022 | Amount | Series B - Avextra | Valuation | Iberis Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avextra
Avextra has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Fastforward Innovations and Iberis Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Iberis Capital is recognized as a leading private equity and venture capital manager in Portugal.
|
Founded Year | Domain | Location | |
|
Tech & life Science focused early stage VC firm investing in North America & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avextra
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avextra
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avextra Comparisons
Competitors of Avextra
Avextra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tilray, iuvo Therapeutics, Canobo, LIO Pharmaceuticals and enua Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Online e-distributor offering cannabis products for medical purposes
|
|
| domain | founded_year | HQ Location |
Licensed cannabis products are imported and wholesaled under pharmaceutical standards.
|
|
| domain | founded_year | HQ Location |
Offers high-quality CBD oils, gels, and hemp products through online sales and retail channels.
|
|
| domain | founded_year | HQ Location |
CRO focused on providing cannabis clinical trial supply & training services
|
|
| domain | founded_year | HQ Location |
Provides certified medical cannabis products to patients, pharmacies, and doctors in Germany.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avextra
Frequently Asked Questions about Avextra
When was Avextra founded?
Avextra was founded in 2004 and raised its 1st funding round 17 years after it was founded.
Where is Avextra located?
Avextra is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Who is the current CEO of Avextra?
Bernhard Babylon is the current CEO of Avextra. They have also founded this company.
Is Avextra a funded company?
Avextra is a funded company, having raised a total of $48.08M across 4 funding rounds to date. The company's 1st funding round was a Series B of $4.82M, raised on Jul 05, 2021.
What does Avextra do?
Avextra was founded in 2004 in Berlin, Germany, where research and development services for medicinal cannabis products are conducted. Operations center on the medicinal cannabis sector, with expertise applied to product formulation and testing. The company is co-led by Bernhard Babylon and David Reckeweg Lecompte as co-founders and co-CEOs. Services are tailored for pharmaceutical and therapeutic applications in the European market.
Who are the top competitors of Avextra?
Avextra's top competitors include Tilray, iuvo Therapeutics and LIO Pharmaceuticals.
What products or services does Avextra offer?
Avextra offers THC/CBD Quick Test and Cannabis Extract.
Who are Avextra's investors?
Avextra has 2 investors. Key investors include Fastforward Innovations, and Iberis Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.